Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update

Top-line data from Phase 2 CHAPTER-1 prophylactic study anticipated by YE2023Participated in an End-of-Phase 2 meeting with the FDA; initiation of global Phase 3 clinical study anticipated within...

Related Keywords

United States ,Germany ,Israel ,Ukraine ,Russia ,Switzerland ,German ,Berndt Modig ,Marca Riedl ,Joan Mendivil ,Drug Administration ,International Accounting Standards Board ,Hereditary Angioedema International Haei Regional Conference ,Exchange Commission ,International Financial Reporting Standards ,American College Of Allergy ,Asia Pacific Association Of Allergy ,European Union ,Development Rd Expenses ,International Conference ,German Allergy Congress ,Clinical Immunology Society Of Singapore ,Consortium Of Independent Immunology Clinics ,Chief Executive Officer ,Angioedema International ,Regional Conference ,Independent Immunology Clinics ,Asia Pacific Association ,Clinical Immunology ,Clinical Immunology Society ,Foreign Private Issuer ,International Accounting Standards ,Statement Regarding Forward Looking ,Annual Report ,Markets ,